October, 2020 | TIO Bioventures

Treadwell Announces Initiation New Clinical Trial CFI 400945

Treadwell Announces Initiation of New Clinical Trial of CFI-400945 in Patients with Metastatic Castrate-Resistant Prostate Cancer...

TIO Bioventures Launches TCRyption Inc., a Novel TCR-T cell based Immunotherapy...